Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy-Reference-Cited by-同舟云学术

Changes in hepatitis C viral load during first 14 days can predict the undetectable time point of serum viral load by pegylated interferon and ribavirin therapy

Published:2011-02-21 Issue:3 Volume:41 Page:217-224
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:

Author:

Itakura Jun,Asahina Yasuhiro,Tamaki Nobuharu,Hirayama Itsuko,Yasui Yutaka,Tanaka Tomohiro,Sato Mitsuaki,Ueda Ken,Kuzuya Teiji,Tsuchiya Kaoru,Nakanishi Hiroyuki,Kurosaki Masayuki,Gabriel Gretchen S.,Schneider George J.,Izumi Namiki

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1872-034X.2010.00768.x/fullpdf

Reference18 articles.

1. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C;Glue;Hepatology,2000

2. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C;Reddy;Hepatology,2001

3. Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment;Sánchez-Tapias;Gastroenterology,2006

4. Factors predictive of response to interferon- therapy in hepatitis C virus infection;Tsubota;Hepatology,1994

5. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection;Chayama;Hepatology,1997

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research;Gastroenterology Research and Practice;2015

2. Pharmacokinetic/Pharmacodynamic Predictors of Clinical Potency for Hepatitis C Virus Nonnucleoside Polymerase and Protease Inhibitors;Antimicrobial Agents and Chemotherapy;2012-04-02

3. Molecular methods for pathogen and microbial community detection and characterization: Current and potential application in diagnostic microbiology;Infection, Genetics and Evolution;2012-04